Skip to main content
FDA Shortage Check

Is Ifex (Ifosfamide Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Ifex: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Requirements related to complying with good manufacturing practices”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: November 2026”. Manufacturer’s estimate, Baxter Healthcare, Oct 16, 2026
DRUG
Ifex
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Jun 12, 2026
LAST FDA UPDATE
Oct 16, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 8 presentations: 3 unavailable · 1 limited · 4 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Ifosfamide Injection. 8 presentations from 4 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Baxter Healthcare4 presentations · 1 unavailable · 3 available or not stated

Contact (FDA's listing): 888-229-0001

  • 3 g/60 mL

    IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)

    Estimated recovery: November 2026

    NDC 0338-3993-01Reverified

    Unavailable

  • 1 g/20 mL

    IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)

    NDC 0338-3991-01Reverified

    Available

  • 1 g/20 mL

    Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)

    NDC 10019-925-01Reverified

    Available

  • 3 g/60 mL

    Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)

    NDC 10019-926-02Reverified

    Available

Fresenius Kabi USA, LLC1 presentation · 1 limited

Contact (FDA's listing): 888-386-1300

  • 1 g/1

    Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10)

    Check wholesalers for inventory

    NDC 63323-142-10Reverified

    Limited Availability

Hikma Pharmaceuticals USA, Inc.2 presentations · 2 unavailable

Contact (FDA's listing): 800-631-2174

  • 50 mg/1 mL

    Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)

    Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.

    NDC 0143-9530-01Revised

    Unavailable

  • 50 mg/1 mL

    Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)

    Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.

    NDC 0143-9531-01Revised

    Unavailable

SteriMax, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 877-373-4657

  • 1 g/1

    Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)

    To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418

    NDC 21586-211-02New

    Available

What the manufacturers told FDA

  • Baxter Healthcare · ‘Estimated recovery: November 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Requirements related to complying with good manufacturing practices

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Ifex in shortage?
Yes. As of Oct 24, 2026, FDA lists Ifosfamide Injection as currently in shortage: 8 presentations, 3 unavailable and 1 limited.
When will the Ifex shortage end?
FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Ifex?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.